Aarti Drugs Limited (AARTIDRUGS)

459.1

INR
-3.10(-0.67%)
As of December 4, 2024 10:00:00 AM

Aarti Drugs Limited Share Price Information

24 hour Low and High

Low: 457.3
High: 463

All time High

1001.57

Price Change 1h

+₹1.80 +0.39%

Price Change 1d

+₹1.80 +0.39%

Price Change 1w

+₹-10.25 +-2.18%

Aarti Drugs Limited Market Information

Exchange

NSE

Market Cap

4150.06 Cr

About Aarti Drugs Limited Share

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Sector

Healthcare

Drug Manufacturers—Specialty & Generic

Employees

about

1064

CEO

Mr. Prakash Moreshwar Patil

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Stocks to watch on September 23: Vodafone Idea, HFCL, SpiceJet, Aarti Drugs, Aster DM Healthcare
  • Aarti Drugs share price rises more than 12%: To consider share buyback proposal on 26 August | Stock Market News
  • Aarti Drugs Share Buyback: Stock jumps 10% as firm to repurchase shares at a 60% premium
  • Aarti Drugs surges 13% as board mulls share buyback on August 26
  • Aarti Drugs Buyback: All You Need To Know

FAQs

Aarti Drugs Limited (AARTIDRUGS)

459.1

INR
-3.10(-0.67%)
As of December 4, 2024 10:00:00 AM

Aarti Drugs Limited Share Price Information

24 hour Low and High

Low: 457.3
High: 463

All time High

1001.57

Price Change 1h

+₹1.80 +0.39%

Price Change 1d

+₹1.80 +0.39%

Price Change 1w

+₹-10.25 +-2.18%

Aarti Drugs Limited Market Information

Exchange

NSE

Market Cap

4150.06 Cr

About Aarti Drugs Limited Share

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Sector

Healthcare

Drug Manufacturers—Specialty & Generic

Employees

about

1064

CEO

Mr. Prakash Moreshwar Patil

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Stocks to watch on September 23: Vodafone Idea, HFCL, SpiceJet, Aarti Drugs, Aster DM Healthcare
  • Aarti Drugs share price rises more than 12%: To consider share buyback proposal on 26 August | Stock Market News
  • Aarti Drugs Share Buyback: Stock jumps 10% as firm to repurchase shares at a 60% premium
  • Aarti Drugs surges 13% as board mulls share buyback on August 26
  • Aarti Drugs Buyback: All You Need To Know

FAQs